Nerivio

DEVICE14 trials

Sponsors

Theranica, Children's National Research Institute

Conditions

Acute MigraineAcute Treatment of MigraineChronic MigraineMenstrual MigraineMigraineMigraine in AdolescenceMigraine in ChildrenNew Daily Persistent Headache (NDPH)

Phase 4

Nerivio Efficacy by Time of Treatment Onset

CompletedNCT06976723

TheranicaAcute Treatment of Migraine, Migraine

Start: 2025-05-07End: 2025-06-15Updated: 2025-07-31

Unknown Phase

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

TerminatedNCT04089761

TheranicaAcute Migraine

Start: 2019-10-01End: 2020-05-24Updated: 2021-02-25

Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine

CompletedNCT04161807

TheranicaChronic Migraine

Start: 2019-09-18End: 2020-02-18Updated: 2021-02-16

Efficacy and Safety of Nerivio Device for Acute Treatment of Migraine in People With Chronic Migraine

CompletedNCT04194008

TheranicaChronic Migraine

Start: 2019-11-18End: 2020-08-30Updated: 2021-02-02

Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine

CompletedNCT04600388

TheranicaMenstrual Migraine

Start: 2020-09-09End: 2020-11-10Updated: 2020-12-04

Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)

WithdrawnNCT05310227

Children's National Research InstituteNew Daily Persistent Headache (NDPH)

Start: 2022-02-01End: 2023-09-11Updated: 2025-07-24

Real-world Data Analysis of REN Treatment in Adolescence With Migraine

CompletedNCT05443659

TheranicaMigraine in Adolescence

Start: 2021-01-01End: 2022-08-24Updated: 2025-11-04

Safety of Nerivio in Pregnant Women With Migraine

CompletedNCT05464069

TheranicaMigraine, Pregnancy Related

Start: 2022-08-01End: 2022-12-07Updated: 2025-10-06

Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

CompletedNCT05760638

TheranicaMigraine

Start: 2023-03-01End: 2023-04-02Updated: 2024-11-22

Real World Data Analysis: Impact of High-Frequency REN Treatments As Migraine Preventive Therapy in Adolescence

CompletedNCT05769322

TheranicaMigraine

Start: 2023-04-01End: 2023-05-01Updated: 2024-11-22

A Prospective Post-marketing Observational Study Assessing the Safety and Efficacy of Nerivio for Migraine Prevention.

CompletedNCT05940870

TheranicaMigraine

Start: 2023-07-03End: 2024-08-01Updated: 2024-11-22

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)

CompletedNCT06138756

TheranicaMigraine

Start: 2023-10-01End: 2024-06-01Updated: 2025-09-15

A Survey Study to Assess the Accessibility of the Nerivio Device At School

CompletedNCT06180577

TheranicaMigraine in Children

Start: 2024-02-01End: 2024-05-15Updated: 2024-11-22

Nerivio Long-term Usage in Patients With Migraine

CompletedNCT06738056

TheranicaAcute Treatment of Migraine, Migraine

Start: 2024-12-01End: 2024-12-22Updated: 2025-07-17

Related Papers

Patterns, Barriers, and Preferences of Treating Migraine Within the School Setting: A Survey Study of Students

Children2024-10-25

Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects

Frontiers in Pain Research2023-11-0617 citations

One-Year Consistent Safety, Utilization, and Efficacy Assessment of Remote Electrical Neuromodulation (REN) for Migraine Treatment.

2023-10-195 citations

Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study

PAIN Reports2021-10-1426 citations

Remote Electrical Neuromodulation (REN) for the Acute Treatment of Menstrual Migraine: a Retrospective Survey Study of Effectiveness and Tolerability

Pain and Therapy2021-06-1710 citations

Remote Electrical Neuromodulation for the Acute Treatment of Migraine in Patients with Chronic Migraine: An Open-Label Pilot Study.

2020-07-0922 citations